Introduction
With the advent of next generation sequencing (NGS) technologies, where a large volume of short deoxyribonucleic acid (DNA) sequences (reads) are generated, new methods and techniques have been developed for transcriptome analysis. Ribonucleic acid-sequencing (RNA-Seq) technology, which is based on the direct sequencing of complementary DNA (cDNA) 1 , provides the ability for the reconstruction of transcripts, estimation of mRNA abundances and testing for differential expression (DE) genes between two or more conditions. This technology has enabled researchers and scientists to study the transcriptome at an unprecedented rate and has lately become a common platform for transcriptome analysis. This technique offers several advantages over the old microarray technology 2 . For instance, whereas microarrays generate expression signal intensities, RNA-Seq data generates digital gene expression counts. Unlike microarrays, RNA-Seq has a low background noise with high resolution. While microarrays offer resolution at the probe length, RNA-Seq allows for a single base resolution. Such granularity allows for the detection of splice variants. The dynamic range for quantifying expression differences is limited to a few hundred folds in microarrays, and can be nearly 10,000 fold with RNA-Seq data. One key limitation for microarrays is that they rely on a reference genome while RNA-Seq can take advantage of such an annotation. It also offers the ability for de novo transcriptomics.
An RNA-Seq experiment starts with the extraction of total RNA or a portion, such as polyadenylated-RNA 2 . The extracted RNA is then converted to a library of doublestranded cDNA and sheared into small fragments. In the next step, adapters are attached to one or both sides of each cDNA fragment. Using NGS platforms, such as Illumina's HighSeq 2500, Roche 454 GS FLX Sequencer, Applied Biosystems SOLiD Sequencer, Helicos HeliScope, or Pacific Biosciences/RS sequencer ( Table 1 shows more detailed information about the most recently NGS platforms), each cDNA fragment is sequenced and a short sequence (read) from one end of the fragment (single-end tag) or from both ends (paired-end tag) is obtained ( Figure 1 ). The obtained reads are mapped to the reference genome or transcriptome to measure the abundance of each transcript. If the reference genome or transcriptome is not available, short sequences (reads) can be assembled de novo to identify the full set of transcripts, followed by abundance estimation.
One of the primary applications in RNA-Seq is the study of gene expression profiling across experimental conditions. The number of reads that map to a gene is an approximation of its expression at the transcription level. Thus, the study of determining which genes have changed significantly in terms of their expression across biological samples is referred to as DE analysis. This step is essential in any RNA-Seq study. Identifying which genes are DEs between samples help researchers to understand the functions of genes in response to a given condition. In this review, we examine the most recently developed and widely used methods for DE analysis. We observe different statistical models that each method uses to test for DE. Because a large number of methods and tools have been developed in the last few years for DE analysis, not all DE methods . A comprehensive list of the DE methods can be found in Table 2 .
Background
The detection, of which genes have significant DE across samples, requires the use of statistical hypothesis tests to model RNA-Seq count data. For any DE analysis, the following three components should be considered: normalisation of read counts, statistical modelling of gene expression and testing for DE 8 .
Normalisation
In order to derive an accurate comparison within and between samples, normalisation is performed on read counts to adjust for sequencing depth variations and other systematic technical variations, which results in a comparable data across conditions. Thus, to discover significant changes in expression, studies have shown that normalisation is an essential step in the analysis of DE. Several normalisation techniques have been proposed in the published literature. Marioni et al. 9 used the total read count (TC) to normalise read counts. This normalisation method divides transcript read count by the total number of reads as follows:
where X ij is the number of reads for gene i in sample j and N j is the number of reads in sample j (library size). Such an approach is equivalent to the total intensity normalisation procedure applied for microarrays. Bullard et al. 10 proposed a method similar to the TC method, quantile Licensee For each sample, the DESeq scaling factor is computed for each gene as the median of the ratio of its read count over its geometric mean across all samples 5, 8 . Using the assumption that most genes are not DE, DESeq uses the median of ratios associated with each sample to obtain the scaling factor. NOISeq, as proposed by Tarazona et al. 13 , uses several options for normalisation, including TMM, RPKM and UQ. The Bioconductor package Linear Models for Microarray Data (limma) 14 , an R package designed initially for DE analysis of microarray data, but lately is adapted for RNA-Seq data, implements quantile normalisation. EBSeq 15 provides two choices for normalisation, either by using the median of scaled counts used in DESeq or by using quantile normalisation approach. PoissonSeq 16 uses a normalisation procedure, which assumes a Poisson model for the data.
Statistical modelling of gene expression
The detection of which genes have changed significantly between biological samples, requires the use of statistical hypothesis tests, to model count data from RNA-Seq experiments. Currently, most statistical models are based on parametric assumptions for modelling RNA-Seq data. Discrete probability distributions, such as binomial, Poisson and negative binomial (NB) distributions, have been used to model RNA-Seq count data 12 . In RNA-Seq studies that use a single source of RNA, the distribution of counts across technical replicates for the majority of the gene was indeed Poisson 12, 17 , in the form of f (n, y) = ( n e -)/n!, where n is the number of read counts and λ is the expected number of reads in each transcript 8 . Early methods, such as the likelihood ratio test (LRT) proposed by Marioni et al., DEGSeq, PoissionSeq and Gpseq
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, have been developed to detect database of essential genes (DEGs) based on this distribution. However, the Poisson distribution suffers from the inability to capture biological variability within RNA-Seq data 12, 17 , because the variance of the Poisson distribution is equal to the mean. Because the variance of many genes is likely to exceed the mean, this results in over-dispersion. Thus, Poisson-based analyses using biological replicates will be prone to high false positive rates.
To address over-dispersion and account for biological variability, methods such as edgeR, DESeq, baySeq and Cuffdiff, have been developed based on the NB distribution to model read counts. These methods the relationship between the variance v and mean μ. For example, edgeR and DESeq define this relationship as v = μ + αμ 2 , where α is the dispersion factor. edgeR provides two options for α, a common dispersion (estimated from all genes) and tag-wise dispersion (estimated for individual genes) 4, 12, 19 . DESeq, on the other hand, estimates the dispersion parameter by using a combination of two terms for the variance, one term estimates the Poisson (the mean expression μ), and the second terms is the raw variance of the gene used to model the biological expression variability 5, 8 . Cuffdiff computes two variance models, i.e., one for single-isoform genes and one for multi-isoform genes. For singleisoform genes, Cuffdiff computes the expression variance similar to DESeq using NB distribution. When a gene has multiple isoforms, Cuffdiff models over-dispersion by using the beta NB distribution 7 . BaySeq differs from the above three methods and implements an empirical Bayesian model based on NB distribution. This model estimates the prior probability parameters by bootstrapping from the data and then applies the maximum likelihood method. PoissonSeq models RNA-Seq count data by using a Poisson loglinear model. The mean μ ij in this model is defined as a log-linear model logμ ij = logd i +logβ j + Υ j Υ i , where, d i is the library size of sample i, β j is the expression level of gene j, and Υ j is the correlation of gene j with condition y i 8, 9, 16 . If there is no association between gene j and y i , then Υ j = 0 and Υ j ≠ 0 otherwise.
Testing for diff erential expression
Once the parameters are estimated, statistical tests such as t-test, Wilcoxon test, or Fisher's exact test (FET), can be applied on the normalised data, to detect significant differentially expressed genes between samples. Both DESeq and edgeR use a variation of the FET adopted for an NB distribution. Cuffdiff compares the log ratio of gene expression in two conditions against the log ratio of one and calculates the test statis-
tics as follows: T = E[log(y)] Var[log(y)]
, where Y, is the log ratio of the normalised counts between the two conditions (Y =
FPKM a FPKM b
). baySeq employs an empirical Bayesian approach to determine DE between these conditions. For every gene, baySeq estimates two models, one assumes that the expression pattern is the same and a second assumes that the expression pattern is different across conditions. Thus, the posterior likelihood can be estimated using the prior estimates and the likelihood of the distribution of the data to decide if a gene is differentially expressed. PoissonSeq tests for DE by determining the significance of the correlation term Υ j in the linear model using a score statistic 8, 16 . The p-value is then derived using a chi-square distribution, because the score statistic is shown to follow this distribution. Other DE methods use different statistical tests to test for DEGs. For example, limma uses a moderated t-statistic to derive the p-value.
Methods

Cuffdiff
Cuffdiff is a Cufflinks module that aims to find significant changes in transcript expression, splicing, coding output and promoter use. It uses the Cufflinks transcript quantification module to calculate transcript/gene expression levels and tests them for significant changes. The main input of Cuffdiff is the reference transcripts as a gene transfer format (GTF) file and two or more sequence alignment map (SAM) or binary version of SAM (BAM) files containing the fragment alignments for two or more samples. The output of Cuffdiff is a set of several files containing changes in expression at the level of isoforms, primary transcripts and genes. To test for DE, Cuffdiff compares the log ratio of gene expression in two conditions against the log ratio of one and calculates the test statistics. This ratio requires the knowledge of the variance of the expression level in each condition, which is calculated for a transcript's expression levels as follows: . Along with those two methods, three existing methods, FET, LRT and samWrapper, have been integrated into DEGSeq to identify differential expressed genes. In the MA random sampling, RNA sequencing can be modelled as a random sampling process, where each read is sampled independently and uniformly from every possible nucleotide in the sample. Thus, the number of reads coming from a gene/ transcript follows a binomial distribution, which can be approximated by a Poisson distribution. With this assumption, DEGSeq is not applicable to data with over-dispersion, which limits its use for RNA-Seq analysis. The input of this package is uniquely mapped reads, a gene annotation of the corresponding genome, and gene expression counts for each sample. The output includes a text file, which contains the gene expression values for the samples, a P-value and two kinds of Q-values (adjusted p-values) and an extensible hypertext markup language (XHTML) summary page.
DESeq
DESeq is an R Bioconductor package that analyses RNA-Seq count data using the NB distribution and an estimator of the distribution's variance.
DESeq uses a similar statistical model to edgeR, with a few extensions allowing for more general datadriven relationships of variance and mean. Under the assumption of a locally linear relationship between variance and mean expression levels, the variance can be estimated using data with similar expression levels 12 .
The input of DESeq is a table of count data that reports for each sample, the number of reads that have been assigned to a gene. Thus, a table cell in the i-th and j-th column represents the number of reads mapped to gene i in sample j. The output is a list of differentially expressed genes with p-values and q-values. The NB distribution that DESeq uses to model count data is defined as follows:
, where, K ij denotes the read counts for gene i in sample j. This model has two parameters, the mean μ ij and the variance  ij 2 . These two parameters are often not known in advance and therefore, have to be estimated from the data. The mean μ ij can be defined as follows: μ ij = q i ,p(i) S j, which is the product of the expected read count (per gene and condition) q i ,(j) and size factor S j , which represents the coverage of library j. (j) is the experimental condition of sample j. In contrast, the variance is defined as follows:
, is the per gene raw variance parameter. This parameter is assumed to be a smooth function of qi, and defined as follows: (j) ), which should allow the pooling of data from genes with similar expression strength. To perform testing, DESeq uses FET on NB data. Thus, for two conditions A and B, the null hypothesis is that the counts of the two conditions are equal (q iA =q iB ). The test statistic is performed using FET and the p-values computed using the following formula:
where k iA , and k iB are the TCs in each condition and k iS = k iA + k iB . Variables a and b denote the even probabilities for any pair of numbers a and b. For more details about the computation methods of the above models, refer to DESeq in the work of Anders and Huber
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. baySeq baySeq is an R Bioconductor package that assumes the data follows a NB distribution. baySeq differs from the above two packages in the strategy of estimating significance by employing an empirical Bayesian approach to determine DE across conditions. The baySeq approach starts by first bootstrapping to estimate prior parameters from the data and then assessing posterior likelihoods of the models by applying either maximum likelihood or quasi-likelihood methods 19 . In general, the baySeq approach aims to identify the behaviour of samples in terms of similarity and difference for each given model. Thus, for each gene, there will be two hypotheses, either the expression pattern is the same or different between two conditions. Under these two hypotheses, the posterior likelihood can be estimated using the prior estimates and the likelihood of the distribution of the data to decide if a gene is differentially expressed. The statistical models of baySeq are based on both Poisson and NB distributions.
The Poisson distribution is defined as follows: Y gij (M j p gi ), assuming that the prior p gi follows a gamma distribution p gi = Γ(α gi ,β gi ). The second model, which is based on the NB distribution is defined as follows: of this review was on the most widely used methods, including edgeR, DESeq, DEGSeq, baySeq and Cuffdiff. We have looked at the following three main aspects: the normalisation procedure used by each method, the statistical model used for modelling RNA-Seq data and how each method tests for DE. In addition, we have given a brief description of the popular DE methods that are used by the majority of RNA-Seq community.
There is no an agreement in the published literature that a certain method is the optimal method under all circumstances. Thus, the reviewed methods perform differently under different conditions; hence, the choice of which particular method is to be used for a particular case depends on the experimental conditions 20 . Several comparison studies have been conducted in the literature evaluating DE methods to compare their performance under different conditions and using different datasets. Yet, there is no clear conclusion of those studies that certain methods are recommended to use for particular situations. Here, in this review, we tried to summarise the findings and observations of some of those studies in order to show the performance of the methods reviewed. Gao et al. 19 reviewed three R Bioconductor packages, namely, edgeR, DEGSeq, and baySeq. In their survey, they concluded that baySeq takes the longest time to run, DEGSeq is the easiest to use, but it does not handle over-dispersion data and edgeR is the most flexible package handling both Poisson and over-dispersion data 19 . Rapaport et al. 8 conducted a comprehensive evaluation of the commonly used DE methods using the Stroke Evaluation and Quality Committee (SEQC) benchmark data sets. Several features were evaluated in this study, including normalisation, accuracy of DE detection, modelling of gene expression and the effect of sequencing depth and number of replications on the process of DE detection. As a result of their evaluation, the authors found a significant difference between the methods with no single method, outperforming the others. However, by using different measurements, such as receiver operating characteristic (ROC) analysis and significant number of false positives, DE methods that model the data based on NB distribution (e.g., edgeR, DESeq and baySeq), have improved sensitivity and specificity. In addition, they were able to improve the control of false positive errors. This does not mean that those methods outperform the others. Methods, such as PoissonSeq and limma, which are not based on NB distribution, performed better as well. In some cases, PoissonSeq was just as good as edgeR and DESeq. Cuffdiff on the other hand did not perform as well as other methods, and has reduced sensitivity and specificity. Furthermore, they also found that limma, which was developed for microarray analysis, had a comparable performance.
Another comparison study was done by Kvam et al 12 .
In this study, seven DE methods (not including Cuffdiff and PoissonSeq), were compared using a variety of simulations generated, based on different distribution models and real data. Using ROC curves and area under the ROC curves (AUC) as measures, Kvam et al. found that baySeq performs the best among others and ranks the highest number of truly DE genes. edgeR and DESeq perform similarly and close to baySeq, which is expected, because both methods use similar statistical models (based on NB) to model count data.
Soneson et al. 20 conducted another comparison between 11 DE methods (not including Cuffdiff and PoissonSeq). All compared methods in this study are R Bioconductor packages, which take the table of counts described above as an input. These 11 methods were evaluated using simulated and real data. The main focus in this study was on the following three aspects: the performance of ranking truly DE genes, type I error control and FDR and the computational time requirement. The AUC was used as a measure to evaluate the performance of each method. They concluded that all compared methods perform similarly when large sample sizes are used with a strong dependency on sample size for TSPM, EBSeq, SAMseq and baySeq. With the smallest sample sizes, DESeq, edgeR, NBPSeq and limma, performed the best among other methods. For controlling type I error, six methods which generate p-values were evaluated. The performance of the six methods was high with the note that DESeq was the most conservative among the six methods. TSPM and NBPSeq found the highest number of false positives. From their conclusion, limma performed well under many conditions and was not affected by outliers. In addition, it was computationally efficient. However, it has the limitation of requiring at least three replicates per sample to provide good results. SAMseq performed well with large samples, but like limma it requires at least 4-5 replicates per sample to have a good performance. TSPM as mentioned above was the most affected method by sample size. Because edgeR, DESeq, and NBPSeq uses similar statistical models to model count data, their performance was similar in terms of accuracy. Table 2 in Soneson et al. 20 summarises the findings and observations of this study.
As a process of evaluating and testing, our newly developed method, Island-Based (IB), we compared its performance to three DE methods, namely, Cuffdiff, DESeq and edgeR using two benchmarks MicroArray Quality Control (MAQC) RNA-Seq datasets. By using the AUC as a measure, our approach outperforms other methods in both the datasets. The performance of Cuffdiff was better than DESeq and edgeR, (both performed similarly) but not as well as our approach (Figure 2 
Conclusion
From the above discussion, we can conclude that no single DE method can be considered as the best among the available methods. Some methods perform well in particular situations, but their performance is poor in other situations. While some methods require a number of biological replicates for each condition to perform well, others are not conservative and they work with/without replicates. There are several factors that affect the performance of detecting which genes are differentially expressed between samples. Examples of those factors are the normalisation procedure and the statistical model used. DE methods in general, differ mainly in those two factors, which make them provide different results and generate different lists of DE genes. 
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